HUYA Bioscience International Competitors and Similar CompaniesClear all
HUYA Bioscience International's competitors and similar companies include R-Pharm-US, Werewolf Therapeutics, Exonate and HCW Biologics.
 HUYA Bioscience International HUYA Bioscience International is a company specializing in the biopharmaceutical products. |  Werewolf Therapeutics Werewolf Therapeutics is an oncology biotherapeutics company that develops cancer treatments designed to focus the body’s immune response to selectively target cancer. |  Exonate Exonate is a biopharmaceutical company with drug discovery programs in ophthalmology, oncology and pain. |  HCW Biologics HCW Biologics is a company developing proprietary immunotherapy candidates to address chronic inflammation through inflammasome modulation and senescent cell reduction. | ||
Founding Date | Founding Date 2004 | Founding Date 2014 | Founding Date 2017 | Founding Date 2013 | Founding Date 2018 |
Type | Type Private | Type Subsidiary | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ Chengdu Shi, CN Guangzhou Shi, CN Hangzhou, CN Shenzhen Shi, CN Shenzhen Shi, CN Suzhou Shi, CN see more | Locations Princeton, US HQ | Locations Cambridge, US HQ | Locations Duxford, GB HQ | Locations Miramar, US HQ |
Employees | Employees 1022% decrease | Employees 109% decrease | Employees 28 | Employees 18 | Employees 40 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 94.4 m | Valuation ($) N/A | Valuation ($) 17.4 m |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income ($37.4m) (FY, 2023) | Net income N/A | Net income ($25m) (FY, 2023) |
Funding | |||||
Latest funding round | Latest funding round $ 7.6m (over 12 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 1.9m (over 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 12.6m | Total funding raised N/A | Total funding raised $ 56m | Total funding raised $ 11.8m | Total funding raised $ 24.3m |
For sources of this data, please see the company profile
View Company Profiles
Werewolf Therapeutics
HQ
Cambridge, US
Employees
28
Werewolf Therapeutics is an oncology biotherapeutics company that develops cancer treatments designed to focus the body’s immune response to selectively target cancer.
View companyExonate
HQ
Duxford, GB
Employees
18
Exonate is a biopharmaceutical company with drug discovery programs in ophthalmology, oncology and pain.
View companyHCW Biologics
HQ
Miramar, US
Employees
40
HCW Biologics is a company developing proprietary immunotherapy candidates to address chronic inflammation through inflammasome modulation and senescent cell reduction.
View company